DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Oral Estradiol Valerate Versus Oral Contraceptive Pill in Invitro Fertilization Patients

Information source: Instituto Valenciano de Infertilidad, IVI VALENCIA
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Infertility

Intervention: Levonorgestrel and ethinylestradiol (Drug); Estradiol valerate (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: Instituto Valenciano de Infertilidad, IVI VALENCIA

Overall contact:
Juan Garcia-Velasco, MD, Email: jgvelasco@ivi.es


The recent controversy regarding the use of pill for cycle planning in GnRH antagonists IVF cycle has driven the search for new ways to plan IVF cycles in order to avoid weekends or to equally distribute the workload. Recently, mid-late luteal phase oral estrogens seem to be as good as the pill. The investigators will compare OCP vs oral estrogens to plan the initiation of IVF cycles.

Clinical Details

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Implantation rate


Minimum age: 18 Years. Maximum age: 38 Years. Gender(s): Female.


Inclusion Criteria:

- 1st or 2nd IVF cycle

- BMI <30 kg/m2

- regular menstrual cycles

- basal FSH <10IU and E2 <60pg/mL

Exclusion Criteria:

- polycystic ovaries

- endometriosis

- previous ovarian surgery

- previous low ovarian response

Locations and Contacts

Juan Garcia-Velasco, MD, Email: jgvelasco@ivi.es

IVI Madrid, Madrid 28223, Spain; Recruiting
Monica Toribio, RN, Email: invesmadrid@ivi.es
Additional Information

Starting date: June 2011
Last updated: December 29, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017